Expert Opinions Differ On Truvada's Bone Density Side Effects

An accurate medical opinion on Truvada's adverse side effects may depend on who you ask


Truvada Bone Lawsuit News

Thursday, July 23, 2020 - Some medical experts think that HIV positive individuals should not fear to develop Coronavirus and continue to take their medication. Confusion abounds, however, as some people are worried that the AIDS management medication may compromise their immune system and cause them to contract the virus. Other AIDS patients have concerns for Truvada's allegedly severe side effects of causing kidney failure and bone breakage.

Researchers quoted by MedTruth.com report that upwards of 6000 people have reported adverse bone density issues after using Truvada to manage their AIDS symptoms. MedTruth tells readers, "The most common side effects of PrEP drugs (Truvada) are headaches, stomach aches, and decreased weight. More serious issues are kidney problems, including kidney failure, too much lactic acid in the blood, serious liver problems, and bone pain, softening, and fractures." Additionally, the author claims, "Almost 6,000 bone breaks have been linked to the drug. A study found that bone mineral density declines by 2-6% in the first two years of Truvada treatment." Truvada lawsuit attorneys offer a free consultation with no obligation to file a lawsuit claim against the makers of Truvada, Gilead.

Other experts disagree with the need to be concerned about Truvada's bone density and kidney damage risks. Medical Express.com (ME) explains in an article titled, "Lower than expected risk of bone density decline with Truvada," that the negative side effects of Truvada (tenofovir) are exaggerated. ME quotes statistics produced by AIDS Research and Human Retroviruses, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. "Researchers have shown that among users of pre-exposure prophylaxis (PrEP) to prevent against AIDS that includes tenofovir (Truvada), those with daily use-very high adherence-had only about a 1% average decrease in bone mineral density in the spine and a 0.5% decline in the hip."

Others in the LGBTQ community insist that attorney advertising for clients has blown the risk of bone breakage out of proportion. Activists claim that client-seeking advertisements on Facebook and other social media websites are "Fake Ads" and have frightened HIV positive individuals from taking their life-saving drug.

Back in 2012, an article published by the National Institute of Health (NIH) titled: "Bone Loss in the HIV-Infected Patient: Evidence, Clinical Implications, and Treatment Strategies," concluded that studies showed that Tenofovir (Truvada) can have a slight negative impact one's bone density and that HIV positive individuals with pre-existing bone density issues such as osteoporosis should be advised that they have a higher risk for bone breakages if they take Truvada.

It may be up to juries to decide if Truvada causes bone density and kidney damage. Individual lawsuits are slated to begin soon by plaintiffs that allege Gilead Sciences of failing to adequately warn of Truvada's bone density and kidney failure side effects. Gilead has updated the Truvada web site to include a warning that patients may develop "Kidney problems, including kidney failure and bone problems, including bone pain, softening, or thinning, which may lead to fractures."

More Recent Truvada Bone Lawsuit News:

No-Cost, No-Obligation Truvada Lawsuit Case Review If You or a Loved One Suffered from Truvada Bone or Kidney Complications

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.